A detailed history of Group One Trading, L.P. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 557,922 shares of ARDX stock, worth $3.23 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
557,922
Holding current value
$3.23 Million
% of portfolio
0.14%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.89 - $9.31 $3.29 Million - $5.19 Million
557,922 New
557,922 $4.13 Million
Q4 2023

Feb 14, 2024

BUY
$3.29 - $6.64 $371,908 - $750,598
113,042 Added 40.26%
393,805 $2.44 Million
Q3 2023

Nov 09, 2023

BUY
$3.3 - $4.83 $797,448 - $1.17 Million
241,651 Added 617.84%
280,763 $1.15 Million
Q2 2023

Aug 09, 2023

BUY
$3.23 - $4.95 $126,331 - $193,604
39,112 New
39,112 $132,000
Q3 2022

Nov 09, 2022

SELL
$0.59 - $1.44 $22,211 - $54,211
-37,647 Reduced 10.08%
336,018 $400,000
Q2 2022

Aug 11, 2022

BUY
$0.51 - $1.17 $89,019 - $204,222
174,549 Added 87.66%
373,665 $220,000
Q1 2022

May 12, 2022

SELL
$0.65 - $1.18 $138,990 - $252,321
-213,832 Reduced 51.78%
199,116 $213,000
Q4 2021

Feb 11, 2022

BUY
$0.86 - $1.7 $231,192 - $457,007
268,828 Added 186.53%
412,948 $454,000
Q3 2021

Nov 12, 2021

BUY
$1.27 - $8.17 $163,916 - $1.05 Million
129,068 Added 857.48%
144,120 $190,000
Q2 2021

Aug 10, 2021

BUY
$6.55 - $8.98 $98,590 - $135,166
15,052 New
15,052 $114,000
Q3 2020

Nov 12, 2020

SELL
$5.25 - $7.08 $9,828 - $13,253
-1,872 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$5.37 - $8.11 $74,170 - $112,015
-13,812 Reduced 88.06%
1,872 $13,000
Q1 2020

May 13, 2020

BUY
$4.35 - $8.79 $68,225 - $137,862
15,684 New
15,684 $89,000
Q4 2019

Feb 10, 2020

SELL
$4.23 - $8.29 $139,535 - $273,462
-32,987 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$2.15 - $6.28 $70,922 - $207,158
32,987 New
32,987 $155,000
Q1 2019

May 13, 2019

SELL
$1.88 - $3.35 $1,316 - $2,345
-700 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$1.66 - $4.16 $106 - $266
64 Added 10.06%
700 $1,000
Q3 2018

Nov 08, 2018

SELL
$3.75 - $4.65 $5,250 - $6,510
-1,400 Reduced 68.76%
636 $3,000
Q2 2018

Aug 14, 2018

BUY
$3.7 - $5.8 $3,833 - $6,008
1,036 Added 103.6%
2,036 $8,000
Q1 2018

May 11, 2018

SELL
$5.05 - $7.9 $4,040 - $6,320
-800 Reduced 44.44%
1,000 $5,000
Q4 2017

Feb 09, 2018

BUY
$4.85 - $7.8 $1,939 - $3,120
400 Added 28.57%
1,800 $12,000
Q3 2017

Nov 15, 2017

SELL
$4.35 - $5.7 $5,959 - $7,809
-1,370 Reduced 49.46%
1,400 $8,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,770
2,770 $14,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $895M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.